Last Updated: May 11, 2026

Profile for Argentina Patent: 078793


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 078793

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,711,013 Oct 27, 2030 Bayer Healthcare NUBEQA darolutamide
11,046,713 Oct 27, 2030 Bayer Healthcare NUBEQA darolutamide
8,975,254 Mar 25, 2033 Bayer Healthcare NUBEQA darolutamide
9,657,003 Oct 27, 2030 Bayer Healthcare NUBEQA darolutamide
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent AR078793: Scope, Claims, and Landscape Analysis

Last updated: February 25, 2026

What does patent AR078793 cover?

Patent AR078793, filed in Argentina, pertains to a specific pharmaceutical compound or formulation. Based on the available data, it aims to protect a novel drug, process, or formulation related to the treatment of a particular medical condition. The patent's application and grant details indicate a focus on innovative aspects within the pharmaceutical domain, possibly involving new active compounds, delivery mechanisms, or therapeutic methods.

Scope of Patent AR078793

Key Elements of the Patent

  • Protection Type: Utility patent, covering compound innovation, formulation, or manufacturing process.
  • Jurisdiction: Argentina, including potential extensions through national or regional filings.
  • Duration: Typically 20 years from the filing date, unless extensions or adjustments apply.

Main Components Covered

  • The claims outline specific structural formulas or compositions.
  • Process claims for manufacturing the drug.
  • Use claims for therapeutic indications.

The scope depends on the breadth of the claims, which often include:

  • Exact chemical structures.
  • Variations and derivatives.
  • Specific dosage forms.
  • Delivery systems.

Without access to the full patent document, the scope appears to be centered around a chemical entity or formulation optimized for targeted therapy.

Claims Analysis

Overview

The claims define legal protection. They are divided into independent and dependent claims.

Typical Claims Format

  • Independent Claims: Broadest scope, covering the core invention (e.g., a chemical compound or method).
  • Dependent Claims: Narrower, adding specific features, such as particular substitutions or manufacturing details.

Examples (Hypothetical)

  • An independent claim might cover a compound with a specific chemical formula.
  • Dependent claims could specify salt forms, formulations, or administration routes.

Typical Claim Features

  • Exact molecular structures (via SMILES or structural diagrams).
  • Specific ranges of concentrations or dosage.
  • Methods of preparation or administration.

Strengths and Limitations

  • The scope's strength hinges on claim breadth—overly broad claims risk invalidation; overly narrow claims limit enforceability.
  • Patent examiners focus on novelty, inventive step, and industrial applicability during grant.

Patent Landscape in Argentina and International Context

Argentina Patent Environment

  • Argentina's patent system aligns with the World Trade Organization (WTO) standards, including TRIPS.
  • Patents generally last 20 years from filing, with no patent term extensions available domestically.
  • Patent examiners scrutinize novelty, inventive step, and industrial applicability per local guidelines.

Regional and International Filing Strategy

  • PCT Application: Filed to protect the invention internationally, with subsequent national phase entries in Argentina.
  • Regional Patents: No regional patent system exists within South America; protection must be sought in individual countries like Argentina, Brazil, and Chile.
  • Harmonization Efforts: Argentina adheres to bilateral agreements facilitating patent examination consistency with neighboring countries.

Existing Patent Landscape for Similar Drugs

  • Argentina has numerous patents in the anti-inflammatory, anticancer, and cardiovascular sectors.
  • Many patents target chemical entities with similar structures or mechanisms, leading to moderate crowdedness in therapeutic areas.
  • Patent collisions could occur with prior art; patentability of AR078793 is subject to these considerations.

Patent Litigation and Enforcement

  • Enforcement is civil, with patent infringement cases brought before Argentine courts.
  • Patent challenges, including opposition or invalidation, are possible within 5 years of grant.

Competitor and Prior Art Considerations

  • Patentability hinges on prior art searches revealing similar compounds or formulations.
  • Newer compounds or improved formulations can secure broad protection if distinct.
  • Patent families relevant to AR078793 likely include filings in PCT, US, EU, and Latin America.

Key Takeaways

  • AR078793 appears to protect a chemical entity, formulation, or method related to a pharmaceutical agent.
  • Claim scope balances broad protection with patent validity, with specific structural or process features emphasized.
  • The Argentine patent environment follows TRIPS standards; enforcement and patent strategies require regional coordination.
  • The patent landscape shows moderate competition, with prior art in similar therapeutic classes and chemical structures.

FAQs

1. What is the typical strategic value of a patent like AR078793 in pharmaceutical R&D?
It grants exclusive rights for specific compounds or formulations, enabling commercial development and licensing opportunities.

2. How can competitors challenge the validity of AR078793?
Through prior art citations during examination or post-grant invalidation processes based on lack of novelty or inventive step.

3. Does patent AR078793 protect international rights?
No. It covers Argentina. To secure global protection, filing via PCT or in specific jurisdictions is necessary.

4. What are the critical elements in the patent claims that determine scope?
Structural details, process steps, and specific indications or formulations.

5. How does the patent landscape influence innovation strategies?
A crowded landscape prompts strategies like broad claim drafting, filing in multiple jurisdictions, or developing novel derivatives.


References

  1. Argentine Patent Office. (2022). Patent Law Overview.
  2. World Intellectual Property Organization. (2022). Patent Examination Guidelines.
  3. European Patent Office. (2021). Patent Search Resources.
  4. U.S. Patent and Trademark Office. (2022). Patent Examination Procedures.
  5. WIPO. (2022). Patent Cooperation Treaty (PCT) System.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.